REQUEST A DEMO
Total
USD $0.00
Search more companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Lessors of Real Estate | Research and Development in Biotechnology (except Nanobiotechnology) | Ambulatory Health Care Services | Offices of Physicians | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals | Hotels (except Casino Hotels) and Motels
Full name: Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy Profile Updated: November 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

The Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy is currently the largest oncology institution in Poland, with three branches located in Warsaw, Gliwice, and Krakow. The Warsaw Center for Oncology has 670 beds and employs 437 doctors. Annually, it provides outpatient care to nearly 400,000 patients and hospitalizes over 50,000 patients. These patients are effectively treated by a team of the country's best oncologists, who utilize highly specialized procedures and therapies.

Headquarters
Ul. Wilhelma Konrada Roentgena 5
Warsaw; Mazowieckie; Postal Code: 02-781

Contact Details: Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.

Website: http://www.pib-nio.pl

Basic Information
Total Employees:
Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.
Outstanding Shares:
Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.
Financial Auditors:
Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.
Incorporation Date:
December 30, 2002
Key Executives
Purchase this report to view the information.
Director
Subsidiaries
Oncotransfer Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.19%
Total operating revenue
19.58%
Operating profit (EBIT)
101.08%
EBITDA
21.7%
Net Profit (Loss) for the Period
185.89%
Total assets
19.91%
Total equity
38.21%
Operating Profit Margin (ROS)
1.68%
Net Profit Margin
2.29%
Return on Equity (ROE)
14.28%
Debt to Equity Ratio
-19.77%
Quick Ratio
0.2%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?